跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE TABLETS 200MG/300MG - PPB Drug Approval Details
Approvals
/
PPB
/
EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE TABLETS 200MG/300MG
Approved
STANDARD
EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE TABLETS 200MG/300MG
VIATRIS HEALTHCARE HONG KONG LIMITED
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
f5bda48065d2a231
Company
VIATRIS HEALTHCARE HONG KONG LIMITED
Type
Standard
Approval Details
Approval Id
f5bda48065d2a231
Product Name
EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE TABLETS 200MG/300MG
Drug Hk Name
EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE TABLETS 200MG/300MG
Registration Code
HK-65715
Company Name
VIATRIS HEALTHCARE HONG KONG LIMITED
Company Detail Path
/organization/viatris-healthcare-hong-kong-limited
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2018-05-02
Company Address
SUITES 2401-07 & 12, 24/F, ONE ISLAND EAST, 18, WESTLANDS ROAD, QUARRY BAY, HONG KONG
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
f5bda48065d2a231
Type
Standard
Back to PPB Approvals